1. Home
  2. PYPD vs VSEE Comparison

PYPD vs VSEE Comparison

Compare PYPD & VSEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYPD
  • VSEE
  • Stock Information
  • Founded
  • PYPD 2008
  • VSEE 2008
  • Country
  • PYPD Israel
  • VSEE United States
  • Employees
  • PYPD N/A
  • VSEE N/A
  • Industry
  • PYPD Medical/Dental Instruments
  • VSEE
  • Sector
  • PYPD Health Care
  • VSEE
  • Exchange
  • PYPD Nasdaq
  • VSEE NYSE
  • Market Cap
  • PYPD 19.4M
  • VSEE 21.5M
  • IPO Year
  • PYPD 2020
  • VSEE N/A
  • Fundamental
  • Price
  • PYPD $3.30
  • VSEE $1.47
  • Analyst Decision
  • PYPD Strong Buy
  • VSEE
  • Analyst Count
  • PYPD 2
  • VSEE 0
  • Target Price
  • PYPD $10.50
  • VSEE N/A
  • AVG Volume (30 Days)
  • PYPD 49.0K
  • VSEE 534.9K
  • Earning Date
  • PYPD 02-12-2025
  • VSEE 02-15-2025
  • Dividend Yield
  • PYPD N/A
  • VSEE N/A
  • EPS Growth
  • PYPD N/A
  • VSEE N/A
  • EPS
  • PYPD N/A
  • VSEE N/A
  • Revenue
  • PYPD N/A
  • VSEE $8,064,925.00
  • Revenue This Year
  • PYPD N/A
  • VSEE N/A
  • Revenue Next Year
  • PYPD N/A
  • VSEE N/A
  • P/E Ratio
  • PYPD N/A
  • VSEE N/A
  • Revenue Growth
  • PYPD N/A
  • VSEE 37.45
  • 52 Week Low
  • PYPD $2.37
  • VSEE $1.12
  • 52 Week High
  • PYPD $7.00
  • VSEE $33.08
  • Technical
  • Relative Strength Index (RSI)
  • PYPD 55.20
  • VSEE N/A
  • Support Level
  • PYPD $2.93
  • VSEE N/A
  • Resistance Level
  • PYPD $3.35
  • VSEE N/A
  • Average True Range (ATR)
  • PYPD 0.24
  • VSEE 0.00
  • MACD
  • PYPD 0.04
  • VSEE 0.00
  • Stochastic Oscillator
  • PYPD 93.15
  • VSEE 0.00

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

About VSEE VSEE HEALTH INC

VSee Health Inc is a telehealth software platform. VSee's telemedicine solution, offering a fast, secure text + video collaboration app HIPAA messenger, and fully customizable virtual waiting rooms and clinics, is a complete telehealth platform that fits into any workflow. The VSee proprietary technology platform and modular software solution enable users to plug and play telehealth services with end-to-end encrypted video streaming integrated with patient metrics, electronic medical records, and other sensitive data, with multiple other interactive functionalities. The company's products include VSee Clinic, VSee Messenger, VSee APIs, VSee Remote patient monitoring, VSee Telehealth Staffing.

Share on Social Networks: